TEAM
Dr. Maria Wanderoy, Director Drug Development
Doctoral degree in Neurochemistry and Neurotoxicology at Stockholm University. More than 25 years experiences from the pharmaceutical industry, e.g., AstraZeneca. Dr. Wanderoy has held positions ranging from global-, clinical- and preclinical project manager to senior research scientist and with that experience a broad understanding of the drug development process. She has also several years of experience as project manager for medical device development projects, for example, autoinjectors used for drug delivery in patients.
LinkedIn profile »
Dr Helena Bergström,
Clinical Pharmacology Physician (CPP)
Doctoral degree in medical science and an experienced clinician that previously also has been involved in research of sex-and gender differences in medicine, drug metabolism and lipidology. She graduated from Uppsala University in 1996. While working as a clinical pharmacology physician for AstraZeneca R&D, Helena was engaged in the planning and execution of first in human studies in neuroscience and cardiometabolic diseases. She has also been co-investigator in numerous studies from phase 1 to 4, and in different therapeutic areas.
LinkedIn profile »
Annu Suchdev, QA Manager
25 years in the pharmaceutical industry with 19 years with quality management. Annu have had roles such as Head of Quality R&D and Healthcare Compliance, QA Manager, GCP Manager, Compliance Officer and Clinical Research Associate within Clinical Development at CROs, big and small pharma and at headquarters and affiliates. Specialties are Good Clinical Practice, Pharmacovigilance, Audits and Inspections, Quality Management and SOPs. Annu has been the lead in building GCP and GVP quality systems, participated in/conducted ca. 150 GVP and GCP audits and 8 PV inspections and been project lead on merging SOP systems in two mergers and chaired the QMS Committee at a global pharma company.
LinkedIn profile »
Dr. Anneli Hällgren, Toxicology and Safety Program
Doctoral degree in physiology at Uppsala University. More than 20 years of experience from non-clinical research and development projects in different indications and product types. Dr. Hällgren had management and other leading positions related to preclinical development and pharmacology in companies such as KaroBio and Melacure Therapeutics.
LinkedIn profile »
Dr. Mats Reslow, CMC
Doctoral degree in biotechnology at Lund University. More than 25 years of experience in research and development in biopharmacology and drug production. Dr. Reslow has worked as research manager at Bioglan Therapeutics AB, Skyepharma and between 2004 and 2016 as Principal Scientist at NovoNordisk A / S.
LinkedIn profile »
Dr. Agneta Wennerholm, Clinical Studies
Doctoral degree in clinical pharmacology at Karolinska Institutet. Dr. Wennerholm has more than 20 years of experience in pharmaceutical and biotechnology companies, academic research and clinical CRO.
LinkedIn profile »
Dr Johan Kolmert, Bioanalytical chemist
Received his PhD in molecular phenotyping of asthmatic patients at the Karolinska Institutet (Sweden). Dr Kolmert has nine years of experience from pre-clinical and clinical biomarker discovery at AstraZeneca R&D as a Senior Scientist. Currently, Dr Kolmert is an active senior researcher in the biology of arachidonic acid/eicosanoid-induced pulmonary inflammation at the Karolinska Institutet. He also act as independent bioanalytical consultant for small start-up pharma companies during their drug development programs.
LinkedIn profile »